MEA Renal Disease Therapeutics Market Research Report

Share on

Middle East and Africa Renal Disease Therapeutics Market Research Report – Segmented By Application, Treatment Devices & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021

ID: 1222

Pages: 145

The size of the Middle East and Africa Renal Disease Therapeutics Market is predicted to grow at a sluggish rate between 2021 to 2026.

Kidneys have numerous functions, such as filtering waste products from blood, regulating blood pressure, and maintenance of salts and minerals. When any form of damage to kidney occurs, they ultimately lose their vital function, which is fatal. Kidney damage/failure can be developed acutely (AKI) and over the time (CKD). Mostly three types of treatment are prevalent to cure the kidney failure, which are prescription medications, surgical intervention, dialysis (peritoneal dialysis, hemodialysis, and continuous renal replacement therapy), which are frequently used in combination to treat a single case of renal failure.

Middle East and Africa Renal disease therapeutics market are driven by Growing aging population, increasing number of individuals with insurance due to the Affordable Care Act, Increasing Diabetic Population, growing awareness of both acute and chronic kidney disease, and growing demand for the advanced diagnostics and therapeutics for the disease. The factors that are hindering the growth of the market are disparities of Renal Transplant Therapy, expiring of patents of some of the branded drugs for the late stage CKD and changing reimbursement scenario in some of major countries, Negative Societal Effects.

The Middle East and Africa Renal Disease Therapeutics market is segmented based on the Application, and treatment. Application mode is segmented into Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, and Anaemia. The treatment segment is further categorized into Dialysis Equipment, Renal Denervation devices, Wearable artificial kidney device, and distal embolic protection devices. On the basis of geography, the Middle East and Africa Renal Disease Therapeutics market is analysed under various regions namely Middle East and Africa.

Some of the companies influencing the Middle East and Africa Renal disease therapeutics market are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, Davita Healthcare Partners.

1.Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

3.3 Epidemology

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

5. Market Segmentation

5.1 Application

5.1.1 Introduction

5.1.2 Kidney Stone Disease

5.1.3 End-Stage Kidney Disease

5.1.4 Kidney Failure

5.1.5 Chronic Kidney Disease

5.1.6 Hypertension

5.1.7 Diabetes

5.1.8 Anaemia

5.1.4 Y-o-Y Growth Analysis, By Application

5.1.5 Market Attractiveness Analysis, By Application

5.1.6 Market Share Analysis, By Application

5.2 Treatment devices

5.2.1 Introduction

5.2.2 Dialysis Equipment

5.2.3 Renal Denervation devices

5.2.4 Wearable artificial kidney device

5.2.5 distal embolic protection devices

5.2.6 Y-o-Y Growth Analysis, By Treatment devices

5.2.7 Market Attractiveness Analysis, By Treatment devices

5.2.8 Market Share Analysis, By Treatment devices

6. Geographical Analysis

6.1 Introduction

6.1.1 Regional Trends

6.1.2 Impact Analysis

6.1.3 Y-o-Y Growth Analysis

6.1.3.1 By Geographical Area

6.1.3.2 By Application

6.1.3.3 By Treatment Devices

6.1.4 Market Attractiveness Analysis

6.1.4.1 By Geographical Area

6.1.4.2 By Application

6.1.4.3 By Treatment devices

6.1.5 Market Share Analysis

6.1.5.1 By Geographical Area

6.1.5.2 By Application

6.1.5.3 By Treatmentr Devices

6.2 Middle-East

6.3 Africa

7.Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porter’s Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis

8.1 Amgen Inc.

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Financial analysis

8.1.4 Recent Developments

8.1.5 SWOT analysis

8.1.6 Analyst View

8.2 Merck & Co., Inc.

8.3 Bristol-Myers Squibb Company

8.4 Hoffmann-La Roche Inc

8.5 Shire Inc.

8.6 Fresenius Medical Care

8.7 Baxter International

8.8 Davita Healthcare Partners

9.Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

10.Market Outlook and Investment Opportunities

Appendix

a) List of Tables

b) List of Figures

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
to provide both individuals and organizations a strong financial foothold in the marketInvestment opportunitiesExpertly devised analyst overview along with